Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Calvert

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
European Journal of Heart Failure|August 11, 2004
Answering important questions reliably--GISSI Heart Failure, a factorially designed trial with composite (co)primary outcome measuresNick Freemantle, Melanie Calvert
Expert Review of Pharmacoeconomics & Outcomes Research|March 7, 2014
The need for increased harmonisation of clinical trials and economic evaluationsAdrian Gheorghe, Derek Kyte, Melanie Calvert
BMJ (Clinical Research Ed.)|January 17, 2004
Timing of simvastatin treatment: trial is not reported according to CONSORT guidelinesMelanie Calvert, Richard McManus, John MacLeod
JAMA|September 26, 2013
Patient-reported outcome alerts: ethical and logistical considerations in clinical trialsDerek Kyte, Heather Draper, Melanie Calvert
Journal of Clinical Epidemiology|April 2, 2011
Designing "Real-World" trials to meet the needs of health policy makers at marketing authorizationMelanie Calvert, John Wood, Nick Freemantle
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|March 19, 2013
Module evaluation: a comparison of standard evaluation with nominal group techniqueJonathan Ives, John Skelton, Melanie Calvert
JAMA|January 23, 2014
Patient-reported outcome alert monitoring--replyMelanie Calvert, Heather Draper, Derek Kyte
BMJ Oncology|June 23, 2025
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical careMelanie Calvert, Roger Wilson, John Devin Peipert
Pharmacoeconomics|June 13, 2015
Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability IndexAdrian Gheorghe, Tracy Roberts, Karla Hemming, et al.
Annals of Internal Medicine|February 16, 2005
Cardiac resynchronization therapy in heart failureMelanie Calvert, Nick Freemantle, John G F Cleland
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
European Journal of Heart Failure|August 11, 2004
Answering important questions reliably--GISSI Heart Failure, a factorially designed trial with composite (co)primary outcome measuresNick Freemantle, Melanie Calvert
Expert Review of Pharmacoeconomics & Outcomes Research|March 7, 2014
The need for increased harmonisation of clinical trials and economic evaluationsAdrian Gheorghe, Derek Kyte, Melanie Calvert
BMJ (Clinical Research Ed.)|January 17, 2004
Timing of simvastatin treatment: trial is not reported according to CONSORT guidelinesMelanie Calvert, Richard McManus, John MacLeod
JAMA|September 26, 2013
Patient-reported outcome alerts: ethical and logistical considerations in clinical trialsDerek Kyte, Heather Draper, Melanie Calvert
Journal of Clinical Epidemiology|April 2, 2011
Designing "Real-World" trials to meet the needs of health policy makers at marketing authorizationMelanie Calvert, John Wood, Nick Freemantle
Education for Primary Care : an Official Publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors|March 19, 2013
Module evaluation: a comparison of standard evaluation with nominal group techniqueJonathan Ives, John Skelton, Melanie Calvert
JAMA|January 23, 2014
Patient-reported outcome alert monitoring--replyMelanie Calvert, Heather Draper, Derek Kyte
BMJ Oncology|June 23, 2025
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical careMelanie Calvert, Roger Wilson, John Devin Peipert
Pharmacoeconomics|June 13, 2015
Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability IndexAdrian Gheorghe, Tracy Roberts, Karla Hemming, et al.
Annals of Internal Medicine|February 16, 2005
Cardiac resynchronization therapy in heart failureMelanie Calvert, Nick Freemantle, John G F Cleland
Pageof 23